Wello Medical at CMEF 2026: Innovations in Minimally Invasive Devices
With the successful conclusion of the 93rd China International Medical Equipment Fair (CMEF) at the National Exhibition and Convention Center (Shanghai), a major healthcare technology showcase themed “Innovation Fusion · Boundless Leaps” has drawn to a close. At this global gathering of cutting-edge medical technologies, Well Care (Wuhan) Medical Technology Co., Ltd. emerged as a focal point through its strong innovation capabilities and forward-looking product portfolio, highlighting the company’s core strengths in anorectal care, urology, and minimally invasive intervention.

An Innovative Product Portfolio for the Future of Clinical Care
At this CMEF, Wello Medical presented its comprehensive product portfolio across three core areas. Through technological innovation, the company aims to provide improved solutions for clinical practice. Key products—including the Quantitative-Tension Elastic-Thread Anorectal Ligation Stapler, Preputial Ligation Stapler, and biopsy needles—were showcased together and attracted considerable attention from industry experts and visitors. These products reflect Wello Medical’s expertise in precision engineering as well as its deep understanding of clinical needs, with the goal of achieving an optimal balance among procedural standardization, treatment efficiency, and patient experience.

Featured Product: ATH Quantitative-Tension Elastic-Thread Anorectal Ligation Stapler
As one of Wello Medical’s flagship products, the ATH Quantitative-Tension Elastic-Thread Anorectal Ligation Stapler received widespread recognition at the exhibition for its distinctive technical advantages. The product integrates four key features—quantitative control, visualization, synchronization, and safety—helping to improve the efficiency and safety of anorectal disease treatment.


Advances in Urology and Minimally Invasive Intervention
Beyond anorectal care, Wello Medical’s Elastic Thread Circumcision Device for urological surgery and biopsy needles for minimally invasive intervention also demonstrated the company’s strong research and development capabilities. Guided by WeCare’s philosophy—“Quality as Our Foundation, Innovation as Our Path to Growth”—these products combine refined manufacturing with advanced technology to open up new possibilities for the diagnosis and treatment of related conditions.


Looking Ahead: Continuous Innovation for a Healthier Future
The successful conclusion of the 2026 Spring CMEF marks not only an important platform for Wello Medical to demonstrate its capabilities, but also a new starting point for dialogue, collaboration, and shared growth with healthcare professionals around the world. Well Care (Wuhan) Medical Technology Co., Ltd. will continue to uphold the spirit of “Moving Forward Together for a Win-Win Future,” deepen its commitment to healthcare technology innovation, and develop more high-quality, high-performance medical devices—contributing Chinese expertise and innovation to the advancement of global health.



Well Care (Wuhan) Medical Technology Co., Ltd. — Innovative Technology for the Protection of Life and Health!
